-
1دورية أكاديمية
المؤلفون: Jennifer Woyach, Ian W. Flinn, Farrukh Awan, Herbert Eradat, Danielle M. Brander, Michael Tees, Sameer Parikh, Tycel Phillips, Razi Ghori, Ima Paydar, Mohammed Z. H. Farooqui, John C. Byrd, Deborah Stephens
المصدر: HemaSphere, Vol 7, p e7809236 (2023)
مصطلحات موضوعية: Diseases of the blood and blood-forming organs, RC633-647.5
وصف الملف: electronic resource
-
2دورية أكاديمية
المؤلفون: Antoni Ribas, Inge Marie Svane, Paolo Antonio Ascierto, Victoria Atkinson, Razi Ghori, Anna Maria Di Giacomo, Georgina V Long, Henrik Schmidt, Jacob Schachter, Eduard Gasal, Paola Queirolo, Michal Lotem, Michele Del Vecchio, Pier Francesco Ferrucci, Rosalie Stephens, Mahmoud Abu-Amna, Scott J Diede, Elizabeth S Croydon
المصدر: Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
3
المؤلفون: Scott J. Diede, Michele Del Vecchio, Pier Francesco Ferrucci, Razi Ghori, Wilson H. Miller, Omid Hamid, Paolo A. Ascierto, Marcus O. Butler, Matteo S. Carlino, Antoni Ribas, Eduard Gasal, Elaine McWhirter, Robert Zielinski, Elizabeth Croydon, Michele Maio, Anthony M. Joshua
المصدر: European Journal of Cancer. 160:1-11
مصطلحات موضوعية: Adult, Male, Proto-Oncogene Proteins B-raf, Oncology, Cancer Research, medicine.medical_specialty, Pyridones, Pyrimidinones, Pembrolizumab, Antibodies, Monoclonal, Humanized, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, In patient, Dosing, Adverse effect, Melanoma, Objective response, Aged, Aged, 80 and over, Trametinib, business.industry, Middle Aged, medicine.disease, Maximum tolerated dose, Mutation, Female, business
-
4
المؤلفون: Seock-Ah Im, Kevin Norwood, Donna M. Graham, Hyun Cheol Chung, Esma Saada-Bouzid, Alan D. Smith, Juanita Lopez, Javier Garcia-Corbacho, Carlos Gomez-Roca, Eduardo Castanon, Eduardo Yanez, Federico Longo Muñoz, Corina E. Dutcus, Razi Ghori
المصدر: Cancer Research. 81:PS12-07
مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Chemotherapy, business.industry, medicine.medical_treatment, Phases of clinical research, Cancer, Pembrolizumab, medicine.disease, chemistry.chemical_compound, Breast cancer, chemistry, Internal medicine, medicine, Lenvatinib, business, Progressive disease, Triple-negative breast cancer
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::c1c39d19e7e0f73d0e72aeba6b431dd8
https://doi.org/10.1158/1538-7445.sabcs20-ps12-07 -
5
المؤلفون: Philippe Moreau, Patricia Marinello, Jesús F. San Miguel, Razi Ghori, Mohammed Z.H. Farooqui
المصدر: British Journal of Haematology
مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, medicine.medical_treatment, Low dose, Refractory Multiple Myeloma, Hematology, Immunotherapy, Pembrolizumab, medicine.disease, Carfilzomib, multiple myeloma, Online Only, chemistry.chemical_compound, chemistry, Internal medicine, Correspondence, oncology, Cohort, Medicine, immunotherapy, business, Dexamethasone, Multiple myeloma, medicine.drug
-
6
المؤلفون: Alan D. Smith, Antonio González-Martín, Eduardo Yanez, Bristi Basu, Hyun Cheol Chung, Peter Kubiak, Kevin Norwood, Hélène Senellart, Zarnie Lwin, Philippe A. Cassier, Razi Ghori, Esma Saada-Bouzid
المصدر: Ovarian cancer.
مصطلحات موضوعية: Oncology, medicine.medical_specialty, Performance status, Bevacizumab, business.industry, Phases of clinical research, Pembrolizumab, medicine.disease, chemistry.chemical_compound, chemistry, Response Evaluation Criteria in Solid Tumors, Internal medicine, Cohort, medicine, business, Lenvatinib, Ovarian cancer, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::05c55229b7b64b1aaeb4197266daccd4
https://doi.org/10.1136/ijgc-2020-esgo.116 -
7
المؤلفون: Antonio González-Martín, Kevin Norwood, Zarnie Lwin, H.C. Chung, Eduardo Yanez, Bristi Basu, Alan D. Smith, P. A. Cassier, Esma Saada-Bouzid, Razi Ghori, Peter Kubiak, Hélène Senellart
المصدر: Oral Plenary.
مصطلحات موضوعية: Oncology, medicine.medical_specialty, Bevacizumab, business.industry, Cancer, ECOG Performance Status, Pembrolizumab, medicine.disease, chemistry.chemical_compound, chemistry, Internal medicine, Toxicity, Medicine, business, Lenvatinib, Adverse effect, Ovarian cancer, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::26a0718bffa47dd64e4c1fa0996ba2d5
https://doi.org/10.1136/ijgc-2020-igcs.2 -
8
المؤلفون: Matteo S. Carlino, Paolo A. Ascierto, Omid Hamid, Wilson H. Miller, Razi Ghori, Robert Zielinski, Marcus W. Butler, Antoni Ribas, Pier Francesco Ferrucci, Elizabeth Croydon, Elaine McWhirter, Michele Del Vecchio, Eduard Gasal, Scott J. Diede, Michele Maio, Anthony M. Joshua
المصدر: Poster Presentations.
مصطلحات موضوعية: Oncology, Trametinib, medicine.medical_specialty, business.industry, Melanoma, Dabrafenib, Pembrolizumab, medicine.disease, Placebo, Discontinuation, Tolerability, Internal medicine, medicine, Dosing, business, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::71a78d699c1dbe64b1293dc04e288d92
https://doi.org/10.1136/lba2019.16 -
9
المؤلفون: Mohammed Z.H. Farooqui, Hiromi Iwasaki, Jason J. Z. Liao, Naoki Takezako, Razi Ghori, Kenji Matsuda, Hiroshi Kosugi, Yasushi Onishi, Koji Izutsu, Kenshi Suzuki, Kazutaka Sunami, Shinsuke Iida, Masahiro Kizaki, Yukio Kondo, Takayuki Ishikawa, Itaru Matsumura, Dai Maruyama, Hirokazu Miki, Morio Matsumoto, Yasuhiro Koh, Kensei Tobinai, Takanori Teshima, Kiyoshi Ando, Patricia Marinello, Takashi Shimamoto
المصدر: International journal of hematology. 112(5)
مصطلحات موضوعية: Male, medicine.medical_specialty, Subgroup analysis, Pembrolizumab, Antibodies, Monoclonal, Humanized, Gastroenterology, Risk Assessment, Dexamethasone, Disease-Free Survival, 03 medical and health sciences, 0302 clinical medicine, Asian People, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Medicine, Humans, Adverse effect, Biosimilar Pharmaceuticals, Lenalidomide, Multiple myeloma, Aged, Randomized Controlled Trials as Topic, Aged, 80 and over, business.industry, Hazard ratio, Hematology, Interim analysis, medicine.disease, 030220 oncology & carcinogenesis, Female, business, Multiple Myeloma, 030215 immunology, medicine.drug
-
10
المؤلفون: Razi Ghori, Bo Gao, Maya Gottfried, Anna Maria Di Giacomo, Aaron R. Hansen, Yung-Jue Bang, Jean Pierre Delord, Hyun Cheol Chung, Ravit Geva, Ana De Jesus-Acosta, Andrew K. Joe, Manisha H. Shah, Toshihiko Doi, Aurélien Marabelle, Scott K. Pruitt, Jose A. Lopez-Martin, Dung T. Le, Luis A. Diaz, Paolo A. Ascierto, Ronnie Shapira Frommer, Sarina Anne Piha-Paul, Nicolas Penel
المصدر: J Clin Oncol
مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Cancer Research, Somatic cell, Programmed Cell Death 1 Receptor, Pembrolizumab, Antibodies, Monoclonal, Humanized, DNA Mismatch Repair, Drug Administration Schedule, Young Adult, 03 medical and health sciences, Antineoplastic Agents, Immunological, 0302 clinical medicine, Neoplasms, medicine, Humans, In patient, Infusions, Intravenous, Aged, Aged, 80 and over, business.industry, Cancer, Microsatellite instability, Middle Aged, medicine.disease, 030104 developmental biology, Oncology, Multicenter study, Rapid Communications, 030220 oncology & carcinogenesis, Cancer research, Female, Microsatellite Instability, DNA mismatch repair, business
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a321e5ba15f23115a64669a4cbcefea6
https://europepmc.org/articles/PMC8184060/